BioSpace News Archive

Business

Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor

The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park.

June 6, 2024
·
3 min read
Neurent Medical Announces Publication of Positive Long-Term Results from Study on Chronic Rhinitis Treatment

Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced the publication of positive 12-month results from the CLARITY clinical trial in Laryngoscope Investigative Otolaryngology.

June 6, 2024
·
3 min read
Business

BioHarvest Sciences Announces Record $2 Million Monthly Sales

VINIA Subscription Growth Drives 101% Year-over-Year Increase in May Product Sales Orders; Cumulative Customer Reviews Surpass 5,000

June 6, 2024
·
5 min read
Drug Development

KalVista Pharmaceuticals Presents Data at Eastern Allergy Conference 2024 and the Japanese Dermatological Association 2024

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that it presented the US subgroup analysis from the sebetralstat phase 3 KONFIDENT trial and real-world claims and patient survey data at the Eastern Allergy Conference (EAC) 2024.

June 6, 2024
·
7 min read
Business

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

I-Mab today announced the appointment of Dr. Phillip Dennis as Chief Medical Officer.

June 6, 2024
·
5 min read
Business

Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor

CEL-SCI Corporation announced Dr. Giovanni Selvaggi, an oncology key opinion leader instrumental in successfully bringing several drugs to market has joined CEL-SCI as a Clinical Advisor.

June 6, 2024
·
7 min read
Biotech Bay

BridgeBio Oncology Therapeutics announces first patient dosed with BBO-8520 in the Ph. 1 ONKORAS-101 trial for KRASG12C NSCLC

BridgeBio Oncology Therapeutics announces first patient dosed with BBO-8520 in the Ph. 1 ONKORAS-101 trial for KRAS G12C NSCLC.

June 6, 2024
·
3 min read
Biotech Bay

BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference

BridgeBio Pharma, Inc. today announced that Neil Kumar, Ph.D., founder and CEO of BridgeBio, will present at the Goldman Sachs Annual Global Healthcare Conference in Miami, FL on Wednesday, June 12 at 3:20 pm EDT.

June 6, 2024
·
1 min read
Genetown

Domain Therapeutics Strengthens Its Intellectual Property for Its Series of Treg Depleting anti-CCR8 Antibodies, Including Best-in-class Candidate DT-7012

Domain Therapeutics today announces the publication of three international PCT patent applications.

June 6, 2024
·
2 min read
Drug Development

MicuRx: Successful Completion of Phase I Clinical Trial for Self-Developed MRX-8 Antibacterial Drug in China

Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. successfully completed the Phase I clinical trial of its self-developed new injectable polymyxin antibacterial drug MRX-8 in China, achieving the expected goals.

June 6, 2024
·
5 min read